Supply Chain

DaVita, a Denver-based independent medical group and kidney care services provider, entered into a six-year supply agreement with Thousand Oaks, Calif.-based Amgen.

U.S. District Judge Sue Robinson of Delaware on Jan. 5 granted Amgen's request for a permanent injunction to block Sanofi and Regeneron Pharmaceuticals from marketing its cholesterol drug Praluent, reports National Law Journal.

Transportation and warehousing companies added 14,700 jobs last month, according to the U.S. Department of Labor.

While black people have one of the highest rates of type 2 diabetes in the country, this population is largely underrepresented in drug trials exploring new treatments for the condition, according to a new study published in The Lancet.

Deerfield, Ill.-based Takeda Pharmaceuticals entered into a definitive agreement to acquire Cambridge, Mass.-based ARIAD Pharmaceuticals at $24 per share for a total of $5.2 billion.

U.S. Sen. Amy Klobuchar (D-Minn.) is urging Teleflex Medical to take immediate action in correcting an issue with its nasal applicators for the opioid overdose drug naloxone, reports the StarTribune.

Here are the four latest drugs or medical devices approved by the Food and Drug Administration.

The Food and Drug Administration approved a new use for San Francisco-based Genentech's drug Lucentis.

Singapore-based Global Logistics Properties — the second largest warehouse operator in the world — is for sale, reports The Wall Street Journal.

Novartis has teamed up with Ionis Pharmaceuticals and its affiliate Akcea Therapeutics to license two experimental cardiovascular medications, reports Reuters.